WP
TBIO

Woodline Partners’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Woodline Partners’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-225,683
Closed -$3.72M – 742
2021
Q1 		$3.72M Buy
225,683
+80,840
+56% +$1.84M 0.08% 223
2020
Q4 		$2.67M Buy
+144,843
New +$2.59M 0.07% 187

Other funds holding TBIO

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $143M AUM 25.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Woodline Partners's TBIO Position: Q2 2021 in Review

Woodline Partners sold out of Translate Bio, Inc. Common Stock (TBIO) in Q2 2021, closing a stake of 225,683 shares — an estimated $3.72M sold.

Woodline Partners first reported a position in TBIO in Q4 2020 and held it in 2 quarters. The position peaked at $3.72M in Q1 2021. 145 funds tracked by Wall St. Rank hold TBIO as of Q2 2021.

  • Woodline Partners reported no remaining Translate Bio, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Woodline Partners sold 225,683 Translate Bio, Inc. Common Stock shares in Q2 2021, an estimated $3.72M.
  • Woodline Partners first reported a position in Translate Bio, Inc. Common Stock in Q4 2020 and held it in 2 quarters.
  • Woodline Partners's Translate Bio, Inc. Common Stock position peaked at $3.72M in Q1 2021.
  • 145 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q2 2021.

Based on Woodline Partners's 13F filing for Q2 2021, filed 16 Aug 2021.